Clin2
NCT07268469Possibly a fitNot yet recruiting

Tiny cancer DNA in blood after surgery for solid tumors

Breast CancerNon Small Cell Lung CancerProstate CancerHigh Grade Serous Ovarian CancerGastric Cancer

Part of Cancer, Digestive system, Kidney & urinary, Lungs & breathing, Skin clinical trials.

This study looks at tiny amounts of cancer DNA left in the blood after surgery for solid tumors. It aims to understand how well surgery works and if more treatment is needed.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
840 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 or older
  • You are scheduled for surgery that aims to cure your cancer
  • You have one of these cancers: stage II or III breast cancer, stage II or III non-small cell lung cancer, relapsed high-grade serous ovarian cancer, high-risk prostate cancer, or stomach cancer that has spread to lymph nodes or nearby tissues
  • You have not had another cancer treated in the last 2 years
  • You are willing to give blood samples before and after surgery

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07025785Recruiting
Testing for tumor DNA in blood after early-stage breast cancer surgery

This study looks for tiny bits of tumor DNA in your blood after surgery to see if it can help guide future treatment. It's for people who had surgery first (not chemotherapy before surgery) and have not seen the cancer spread.

Chapel Hill, North Carolina
NCT05965024Recruiting
Using ctDNA blood tests to predict lung cancer return after surgery

This study checks whether a special blood test (ctDNA) taken before and after surgery can predict whether non-small cell lung cancer will come back. If it works, it may help doctors spot recurrence earlier and guide follow-up care after tumor removal.

Shanghai, Shanghai Municipality
NCT05254782Recruiting
Blood test after lung tumor surgery to find hidden disease

This study uses a special blood test to look for tiny traces of lung cancer after surgery. It aims to find “minimal residual disease,” meaning cancer cells that may still be hiding after your tumor is removed.

Toronto, Ontario
NCT06893133Recruiting
DNA testing after gastric cancer surgery

This study checks if a blood test can find leftover cancer DNA after stomach cancer surgery. It helps doctors know if more treatment is needed.

Beijing, Beijing Municipality
NCT04966663Recruiting· Phase 2
Using blood DNA tests to guide lung cancer treatment

This study uses a blood test called ctDNA to look for leftover lung cancer after surgery. Based on that result, the trial will help decide which treatment approach is best for you and may catch cancer returning earlier.

Toronto, Ontario
NCT02838836Recruiting
Checking for cancer DNA and tumor cells in bodily samples

This study looks for cancer-related material in blood, urine, and sometimes bone marrow. It may help researchers understand how to detect cancer activity and track it over time using less invasive tests.

Columbia, Missouri

Hear when a new Breast cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.